Role of oral semaglutide therapy on incidence of cognitive impairment in a cohort of elderly diabetics with Heart failure with preserved ejection fraction

17 May 2025 (08:55 - 09:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Professor Angela Sciacqua

Magna Graecia University of Catanzaro, Catanzaro (Italy)

3 More presentations in this session

Presentation thumbnail

Prognostic implications of abnormal right ventricular-pulmonary artery coupling assessed by three-dimensional echocardiography in heart failure with preserved ejection fraction

Professor C. Shim (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Red cell distribution width (RDW) and outcomes in HFmrEF/HFpEF: Insights from FINEARTS-HF

Doctor J. Butt (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Higher prognostic impact of heart failure patients with preserved ejection fraction at younger age: insights from standardized mortality ratios

Doctor C. de Terwangne (Brussels, BE)

Abstract Slides Video

Access the full session

Session thumbnail

Personalised approaches to HFpEF: diagnostic tools, biomarkers, and prognostic insights

The Event

Event poster

Heart Failure 2025

17 May 2025 08:55 CET

You may be interested in

Congress Presentation

The impact of GLP-1 receptor agonists on cognitive decline in heart failure patients: a retrospective cohort study using real world data

Congress Presentation

Effect of SGLT2 inhibitors on cognitive function in elderly patients with heart failure: a comparative prospective study

Congress Presentation

Metformin associated lower risk of dementia among heart failure patients: a population-based retrospective cohort study

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources